tiprankstipranks
Trending News
More News >
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
US Market

Bioxytran (BIXT) Income Statement

Compare
20 Followers

Bioxytran Income Statement

Last quarter (Q3 2025), Bioxytran's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Bioxytran's net income was $-282.73K. See Bioxytran’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -7.95K$ -8.29K$ -3.64K$ 0.00$ 0.00
Operating Expenses
$ 2.22M$ 3.82M$ 2.14M$ 4.21M$ 1.27M
Depreciation and Amortization
$ 7.95K$ 8.29K$ 3.64K$ 4.21M$ 1.27M
EBITDA
$ -2.22M$ -3.82M$ -2.13M$ 0.00$ 0.00
Operating Income
$ -2.22M$ -3.82M$ -2.13M$ -4.21M$ -1.27M
Other Income/Expenses
$ -156.94K$ -550.11K$ -523.19K$ -313.61K$ -1.27M
Pretax Income
$ -2.38M$ -4.37M$ -2.66M$ -4.53M$ -2.54M
Net Income
$ -2.37M$ -4.28M$ -2.46M$ -4.35M$ -3.75M
Per Share Metrics
Basic EPS
$ -0.02$ -0.03$ -0.02$ -0.04$ -0.04
Diluted EPS
$ -0.02$ -0.03$ -0.02$ -0.04$ -0.04
Weighted Average Shares Outstanding
138.60M 134.22M 115.14M 106.25M 93.97M
Weighted Average Shares Outstanding (Diluted)
138.60M 134.22M 115.14M 106.25M 93.97M
Currency in USD

Bioxytran Earnings and Revenue History